PUNE, India, October 3, 2016 /PRNewswire/ --
ReportsnReports.com adds "Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" market research report providing comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ovarian Cancer Diagnostic Tests pipeline products.
Complete report on Ovarian Cancer Diagnostic Tests Market with 82 market data tables and 5 figures, spread across 237 pages is available at http://www.reportsnreports.com/reports/699823-ovarian-cancer-diagnostic-tests-medical-devices-pipeline-assessment-2016.html.
Companies discussed in this Fabry Disease Pipeline Review, H2 2016 report include A&G Pharmaceutical, Inc., Abnova Corporation, Almac Diagnostics Limited, ANGLE plc, AroCell AB, ArtemixRx, Augusta University, Aurelium BioPharma Inc., Avant Diagnostics, Inc., Axela Inc., Ayanda Biosystems S.A., Becton, Dickinson and Company, Bioindustry Park Silvano Fumero S.p.A., Ceres Nanosciences, Inc., Chronix Biomedical, Inc., Clarient, Inc., ClavGen Therapeutics LLC, Cleveland Diagnostics Inc., Clovis Oncology, Inc., Courtagen Life Sciences, Inc., Dako A/S, Dana-Farber Cancer Institute, Inc., Diazyme Laboratories, Eventus Diagnostics, Inc., Exiqon A/S, Exosomics Siena SpA, Fahy Gurteen UK Limited, Foundation Medicine, Inc., French National Institute of Health and Medical Research, Ganymed Pharmaceuticals AG, GeneNews Limited, Georgia Institute of Technology, GlycoZym, H. Lee Moffitt Cancer Center & Research Institute, Inc., Ikonisys, Inc., Inanovate (UK) Ltd., InterGenetics Incorporated, IV Diagnostics, Inc., John Hopkins University, KIYATEC Inc., Lab Discoveries Ltd., Laboratorios SALVAT S.A., Laboratory Corporation of America Holdings, Louisville Bioscience, Inc., MabCure Inc., MDNA Life Sciences, Inc., MDxHealth SA, Metabolon, Inc., Milagen, Inc., Myriad Genetics, Inc., Nanosphere, Inc., National University of Singapore, Novel Bio-spectrum Technologies, Inc., Olympia Diagnostics, Inc, Oncgnostics GmbH, Oncimmune (USA) LLC, Orion Genomics LLC, Oryzon Genomics SA, OTraces Inc., PeriRx LLC, Phenomenome Discoveries, Inc., Precision Biologics, Inc., Pronota NV, Protagen AG, Proteomika, Provista Diagnostics Inc., RiboMed Biotechnologies, Inc., Roche Diagnostics International Ltd., Rosetta Genomics Ltd, SomaLogic, Inc., Soricimed Biopharma Inc., Stage I Diagnostics, Inc., SurExam Life Science & Technology Co., Target Discovery, Inc., Teva Pharmaceutical Industries Ltd., The University of Adelaide, The University of Texas MD Anderson Cancer Center, Todos Medical, Transbiomed, SL, Universite de Montreal, University of South Florida, US Biomarkers, Inc., Vermillion, Inc., Vitatex Inc., Vitruvian Biomedical, Inc. and Yale University.
Order a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=699823.
Scope of this report: Extensive coverage of the Ovarian Cancer Diagnostic Tests under development. The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities. The report reviews the major players involved in the development of Ovarian Cancer Diagnostic Tests and list all their pipeline projects. The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage. The report provides key clinical trial data of ongoing trials specific to pipeline products and Recent developments in the segment / industry.
Another newly published market research report titled Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 talks about companies like Abbott Diagnostics, Abcodia Ltd., AXO Science S.A.S., BioMark Technologies Inc., China Sky One Medical, Inc., Digna Biotech, S.L., Drexel University, German Cancer Research Center, Glycotest, Inc., Imperial College London, IntegraGen SA, Matrix-Bio, Inc., NanoString Technologies, Inc., National Cancer Institute, Oncimmune (USA) LLC, Orion Genomics LLC, PleX Diagnostics, ProMIS Neurosciences Inc., Proplex Technologies, Llc, Proteome Sciences Plc, Roche Diagnostics International Ltd., TrovaGene, Inc., University of Rochester, Ventana Medical Systems, Inc., Viomics Inc., XEPTAGEN SpA and Xiamen Zeesan Biotech Co.,Ltd. Liver Cancer Diagnostic Tests market research report of 94 pages is available at http://www.reportsnreports.com/reports/699822-liver-cancer-diagnostic-tests-medical-devices-pipeline-assessment-2016.html.
Explore more reports on Pharmaceuticals.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact: Ritesh Tiwari 2nd floor, metropole, Next to inox theatre, Bund garden road Pune-411001 Maharashtra, India Tel: +1-888-391-5441 [email protected]
Connect With Us on:
Facebook: https://www.facebook.com/ReportsnReports/
LinkedIn: https://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
RSS/Feeds: http: //www.reportsnreports.com/feed/l-latestreports.xml
SOURCE ReportsnReports
Advertisement
ReportsnReports.com adds "Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" market research report providing comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ovarian Cancer Diagnostic Tests pipeline products.
Advertisement
Complete report on Ovarian Cancer Diagnostic Tests Market with 82 market data tables and 5 figures, spread across 237 pages is available at http://www.reportsnreports.com/reports/699823-ovarian-cancer-diagnostic-tests-medical-devices-pipeline-assessment-2016.html.
Companies discussed in this Fabry Disease Pipeline Review, H2 2016 report include A&G Pharmaceutical, Inc., Abnova Corporation, Almac Diagnostics Limited, ANGLE plc, AroCell AB, ArtemixRx, Augusta University, Aurelium BioPharma Inc., Avant Diagnostics, Inc., Axela Inc., Ayanda Biosystems S.A., Becton, Dickinson and Company, Bioindustry Park Silvano Fumero S.p.A., Ceres Nanosciences, Inc., Chronix Biomedical, Inc., Clarient, Inc., ClavGen Therapeutics LLC, Cleveland Diagnostics Inc., Clovis Oncology, Inc., Courtagen Life Sciences, Inc., Dako A/S, Dana-Farber Cancer Institute, Inc., Diazyme Laboratories, Eventus Diagnostics, Inc., Exiqon A/S, Exosomics Siena SpA, Fahy Gurteen UK Limited, Foundation Medicine, Inc., French National Institute of Health and Medical Research, Ganymed Pharmaceuticals AG, GeneNews Limited, Georgia Institute of Technology, GlycoZym, H. Lee Moffitt Cancer Center & Research Institute, Inc., Ikonisys, Inc., Inanovate (UK) Ltd., InterGenetics Incorporated, IV Diagnostics, Inc., John Hopkins University, KIYATEC Inc., Lab Discoveries Ltd., Laboratorios SALVAT S.A., Laboratory Corporation of America Holdings, Louisville Bioscience, Inc., MabCure Inc., MDNA Life Sciences, Inc., MDxHealth SA, Metabolon, Inc., Milagen, Inc., Myriad Genetics, Inc., Nanosphere, Inc., National University of Singapore, Novel Bio-spectrum Technologies, Inc., Olympia Diagnostics, Inc, Oncgnostics GmbH, Oncimmune (USA) LLC, Orion Genomics LLC, Oryzon Genomics SA, OTraces Inc., PeriRx LLC, Phenomenome Discoveries, Inc., Precision Biologics, Inc., Pronota NV, Protagen AG, Proteomika, Provista Diagnostics Inc., RiboMed Biotechnologies, Inc., Roche Diagnostics International Ltd., Rosetta Genomics Ltd, SomaLogic, Inc., Soricimed Biopharma Inc., Stage I Diagnostics, Inc., SurExam Life Science & Technology Co., Target Discovery, Inc., Teva Pharmaceutical Industries Ltd., The University of Adelaide, The University of Texas MD Anderson Cancer Center, Todos Medical, Transbiomed, SL, Universite de Montreal, University of South Florida, US Biomarkers, Inc., Vermillion, Inc., Vitatex Inc., Vitruvian Biomedical, Inc. and Yale University.
Order a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=699823.
Scope of this report: Extensive coverage of the Ovarian Cancer Diagnostic Tests under development. The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities. The report reviews the major players involved in the development of Ovarian Cancer Diagnostic Tests and list all their pipeline projects. The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage. The report provides key clinical trial data of ongoing trials specific to pipeline products and Recent developments in the segment / industry.
Another newly published market research report titled Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 talks about companies like Abbott Diagnostics, Abcodia Ltd., AXO Science S.A.S., BioMark Technologies Inc., China Sky One Medical, Inc., Digna Biotech, S.L., Drexel University, German Cancer Research Center, Glycotest, Inc., Imperial College London, IntegraGen SA, Matrix-Bio, Inc., NanoString Technologies, Inc., National Cancer Institute, Oncimmune (USA) LLC, Orion Genomics LLC, PleX Diagnostics, ProMIS Neurosciences Inc., Proplex Technologies, Llc, Proteome Sciences Plc, Roche Diagnostics International Ltd., TrovaGene, Inc., University of Rochester, Ventana Medical Systems, Inc., Viomics Inc., XEPTAGEN SpA and Xiamen Zeesan Biotech Co.,Ltd. Liver Cancer Diagnostic Tests market research report of 94 pages is available at http://www.reportsnreports.com/reports/699822-liver-cancer-diagnostic-tests-medical-devices-pipeline-assessment-2016.html.
Explore more reports on Pharmaceuticals.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact: Ritesh Tiwari 2nd floor, metropole, Next to inox theatre, Bund garden road Pune-411001 Maharashtra, India Tel: +1-888-391-5441 [email protected]
Connect With Us on:
Facebook: https://www.facebook.com/ReportsnReports/
LinkedIn: https://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
RSS/Feeds: http: //www.reportsnreports.com/feed/l-latestreports.xml
SOURCE ReportsnReports
